Activation of type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during streptococcus pneumoniae infection

Journal of Infectious Diseases

Volumn 210, Issue 3, 2014, Pages 493-503

  Van Maele, Laurye ^a,b,c   Carnoy, Christophe ^a,b,c   Cayet, Delphine ^a,b,c   Ivanov, Stoyan ^a,b,c   Porte, Rémi ^a,b,c   Deruy, Emeric ^a,b,c   Chabalgoity, José A ^g   Renauld, Jean Christophe ^h,i   Eberl, Gérard ^d,e   Benecke, Arndt G ^e,f   Trottein, François ^a,b,c   Faveeuw, Christelle ^a,b,c   Sirard, Jean Claude ^a,b,c  

^a INSERM U1019   (France)

^b Institut National de la Sante et de la Recherche Medicale   (United States)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR   (France)

^e CNRS   (France)

^f INSTITUT DES HAUTES ÉTUDES SCIENTIFIQUES   (France)

^g Universidad de la Republica Instituto de Higiene   (Uruguay)

^h LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

ⁱ DE DUVE INSTITUTE   (Belgium)

Author keywords

Innate lymphoid cells; Interleukin 22; Streptococcus pneumoniae; Toll like receptor 5

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 7 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; THY 1 ANTIGEN; FLAGELLIN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; STEADY STATE; STREPTOCOCCUS PNEUMONIA; SURVIVAL RATE; TYPE 3 INNATE LYMPHOID CELL; BACTERIAL LOAD; BIOACCUMULATION; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; FLOW CYTOMETRY; IMMUNOSTIMULATION; INFECTION PREVENTION; LYMPHOID CELL; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

INNATE LYMPHOID CELLS; INTERLEUKIN-22; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 5;

ANIMALS; FEMALE; INTERLEUKIN-17; INTERLEUKINS; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, KNOCKOUT; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 84904335796     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu106     Document Type: Article

References (46)

1. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-9.
2. Vivier E, Tomasello E, Baratin M,Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-10.
3. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-70.
4. Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-54.
5. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008; 29:958-70.
6. Luci C, Reynders A, Ivanov II, et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 2009; 10:75-82.
7. Sanos SL, Bui VL, Mortha A, et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 2009; 10:83-91.
8. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-5.
9. Eberl G. Development and evolution of RORgammat+ cells in a microbe's world. Immunol Rev 2012; 245:177-88.
10. Dumoutier L, de Heusch M, Orabona C, et al. IL-22 is produced by gammaC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality. Eur J Immunol 2011; 41:1075-85.
11. Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissueinducer cells are interleukin 17-producing precursors to RORC+CD127+ natural killer-like cells. Nat Immunol 2009; 10:66-74.
12. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the Gut. Immunity 2011; 34:122-34.
13. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12:383-90.
14. Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 2013; 190:521-5.
15. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-81.
16. Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14:282-9.
17. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009; 9:556-67.
18. Ishigame H, Kakuta S, Nagai T, et al. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009; 30:108-19.
19. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21:241-54.
20. Kinnebrew MA, Buffie CG, Diehl GE, et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012; 36:276-87.
21. Van Maele L, Carnoy C, Cayet D, et al. TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa. J Immunol 2010; 185:1177-85.
22. Satpathy AT, Briseno CG, Lee JS, et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol 2013; 14:937-48.
23. Taube C, Tertilt C, Gyulveszi G, et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One 2011; 6:e21799.
24. von Bernuth H, Picard C, Jin Z, et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008; 321:691-6.
25. Albiger B, Sandgren A, Katsuragi H, et al. Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell Microbiol 2005; 7:1603-15.
26. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008; 4:e1000159.
27. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009; 119:1899-909.
28. Ivanov S, Fontaine J, Paget C, et al. Key role for respiratory CD103+ dendritic cells, IFN-gamma, and IL-17 in protection against Streptococcus pneumoniae infection in response to alpha-Galactosylceramide. J Infect Dis 2012; 206:723-34.
29. Marques JM, Rial A, Munoz N, et al. Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17-and IFN-gamma-mediated immunity. Immunobiol 2012; 217:420-9.
30. Munoz N, Van Maele L, Marques JM, Rial A, Sirard JC, Chabalgoity JA. Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect Immun 2010; 78:4226-33.
31. Lochner M, Peduto L, Cherrier M, et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgammat+ T cells. J Exp Med 2008; 205:1381-93.
32. Ivanov S, Renneson J, Fontaine J, et al. Interleukin-22 reduces lung inflammation during Influenza Avirus infection and protects against secondary bacterial infection. J Virol 2013; 87:6911-24.
33. Besnard AG, Sabat R, Dumoutier L, et al. Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med 2011; 183:1153-63.
34. McNeela EA, Burke A, Neill DR, et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 2010; 6:e1001191.
35. Kumar P, Thakar MS, Ouyang W, Malarkannan S. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol 2013; 6:69-82.
36. Paget C, Ivanov S, Fontaine J, et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem 2012; 287:8816-29.
37. Sawa S, Lochner M, Satoh-Takayama N, et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011; 12:320-6.
38. Mear JB, Gosset P, Kipnis E, et al. Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and IL-22 associated mucosal response. Infect Immun 2014; 82:306-15.
39. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 2003; 28:648-54.
40. Trunk G, Oxenius A. Innate instruction of CD4+ T cell immunity in respiratory bacterial infection. J Immunol 2012; 189:616-28.
41. Shaw MH, Kamada N, Kim YG, Nunez G. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med 2012; 209:251-8.
42. Chang J, Burkett PR, Borges CM, Kuchroo VK, Turka LA, Chang CH. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc Natl Acad Sci U S A 2013; 110:2270-5.
43. Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 2010; 201:534-43.
44. Sonnenberg GF, Monticelli LA, Alenghat T, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012; 336:1321-5.
45. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 2010; 207:1293-305.
46. Basu R, O'Quinn DB, Silberger DJ, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012; 37:1061-75.